(Q42452477)

31 October 2017

title

Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats (English)

1 reference

convection-enhanced delivery

31 October 2017

main subject

0 references

1 reference

4

Edward H Oldfield

1 reference

31 October 2017

Stuart Walbridge

2

1 reference

31 October 2017

Jeffrey W. Degen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14609170

30 March 2024

Alexander O. Vortmeyer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14609170

30 March 2024

Russell R. Lonser

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14609170

30 March 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

31 October 2017

https://thejns.org/view/journals/j-neurosurg/99/5/article-p893.xml

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

https://thejns.org/downloadpdf/journals/j-neurosurg/99/5/article-p893.xml

30 March 2024

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

30 March 2024

published in

Journal of Neurosurgery

1 reference

31 October 2017

volume

99

1 reference

31 October 2017

issue

5

1 reference

31 October 2017

page(s)

893-898

1 reference

Intracerebral clysis in a rat glioma model.

31 October 2017

cites work

5

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time

30 March 2024

6

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94).

30 March 2024

8

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

Temozolomide delivered by intracerebral microinfusion is safe and efficacious against malignant gliomas in rats.

30 March 2024

10

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.

30 March 2024

11

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

Chronic interstitial infusion of protein to primate brain: determination of drug distribution and clearance with single-photon emission computerized tomography imaging

30 March 2024

12

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors

30 March 2024

13

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

Convection-enhanced selective excitotoxic ablation of the neurons of the globus pallidus internus for treatment of parkinsonism in nonhuman primates

30 March 2024

15

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion

30 March 2024

16

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

High-flow microinfusion: tissue penetration and pharmacodynamics

30 March 2024

18

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy.

30 March 2024

20

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

Preclinical characteristics of gemcitabine.

30 March 2024

23

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone

30 March 2024

25

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study.

30 March 2024

26

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

Chemosensitivity of glioma cells in vitro: a meta analysis.

30 March 2024

31

1 reference

https://api.crossref.org/works/10.3171/JNS.2003.99.5.0893

30 March 2024

Identifiers

1 reference

31 October 2017

1 reference